Autoimmune treatment gets new lease of life

Professor Nathan Karin of the Rappaport faculty of Medicine at Israel’s Technion Institute invented an antibody that activates cells in the immune system, thereby reducing inflammation. After years of development, Pfizer has now signed an agreement to commercialize the product.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published.